IPPRA / Grant Monitor

2026-07-07
← Board

DoW Breast Cancer, Breakthrough Award Level 4

HT942526BCRPBTA4 · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health mental behavioral health ai data science Science & Technology R&D

Closes
2026-09-30 · 85 d
Award ceiling
Award floor
Program funding
$21,000,000
Expected awards
1
Cost sharing
No
Posted
2026-05-04
Instrument
Cooperative Agreement
Characterization · gpt-5.4-mini · 2026-07-07

Supports breast cancer research projects at Level 4 that require clinical trials and include at least two breast cancer consumer advocates, for applicants addressing FY26 BCRP challenges.

Funds
applied research
University
direct
social behavioral
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Clinical trials are required. · Must include at least two breast cancer consumer advocates. · Allows either a single PI or a two-PI Initiating/Partnering PI structure. · For Partnering PI Option, only the Initiating PI submits the pre-application, but both PIs must submit at full application; missing either may cause administrative withdrawal.

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 65 good technical depth: minor; funds applied research
IPPRA 58 good peripheral portfolio topic: public_health; signature methods: community engaged; social/behavioral work is minor; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 4.

Distinctive Features:

· Clinical trials are required.

· The research team must include two or more breast cancer consumer advocates.

· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Apply

View on Grants.gov → CONTACT: Jamie Shortall Grant Officer <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING